These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34845374)

  • 1. Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer.
    Very N; Hardivillé S; Decourcelle A; Thévenet J; Djouina M; Page A; Vergoten G; Schulz C; Kerr-Conte J; Lefebvre T; Dehennaut V; El Yazidi-Belkoura I
    Oncogene; 2022 Jan; 41(5):745-756. PubMed ID: 34845374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
    de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
    PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
    Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
    Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
    Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells.
    Wakasa K; Kawabata R; Nakao S; Hattori H; Taguchi K; Uchida J; Yamanaka T; Maehara Y; Fukushima M; Oda S
    PLoS One; 2015; 10(4):e0123076. PubMed ID: 25881233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model.
    Abu Lila AS; Moriyoshi N; Fukushima M; Huang CL; Wada H; Ishida T
    Cancer Lett; 2017 Aug; 400():223-231. PubMed ID: 27838412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
    Jin L; Yuan F; Dai G; Yao Q; Xiang H; Wang L; Xue B; Shan Y; Liu X
    Cell Mol Biol Lett; 2020; 25():17. PubMed ID: 32174982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
    Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase.
    Milczarek M; Rossowska J; Klopotowska D; Stachowicz M; Kutner A; Wietrzyk J
    J Steroid Biochem Mol Biol; 2019 Jun; 190():139-151. PubMed ID: 30923017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.
    Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
    Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
    Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
    Sakatani A; Sonohara F; Goel A
    Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation inhibition redirects the response of colon cancer cells to chemotherapy from senescence to apoptosis.
    Loison I; Pioger A; Paget S; Metatla I; ; Vincent A; Abbadie C; Dehennaut V
    Cell Death Dis; 2024 Oct; 15(10):762. PubMed ID: 39426963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
    Brody JR; Hucl T; Costantino CL; Eshleman JR; Gallmeier E; Zhu H; van der Heijden MS; Winter JM; Wikiewicz AK; Yeo CJ; Kern SE
    Cancer Res; 2009 Feb; 69(3):984-91. PubMed ID: 19155291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.